Sen. Jim Banks (R-Ind.) wants the Food and Drug Administration to look into foreign-made active pharmaceutical ingredients he ...

It was only a matter of time until the GLP-1 receptor agonist drugs like Ozempic and Wegovy were superseded, and now it looks ...

MIT engineers have devised a new way to deliver certain drugs in higher doses with less pain, by injecting them as a ...

The rapid rise of GLP-1 weight-loss drugs has come with a raucous side show—a wave of copycat drugs unbound by drug patents. The knockoff surge was led by Hims & Hers Health, the telehealth firm ...

In recent years, GLP-1 for weight loss has emerged as a significant breakthrough, capturing the attention of both healthcare providers and individuals struggling with obesity. Glucagon-like peptide-1 ...

Hims & Hers generated $1.5 billion in revenue in 2024, reflecting a 69% year-over-year increase, and achieved $126 million in GAAP net income. The company’s subscriber base reached 2.2 million ...

Hims & Hers is shutting down the dermatology business it acquired in 2021, BI has learned. It said it's closing the skincare site Apostrophe to centralize its teledermatology offerings. Hims ...

Novo Nordisk wasted no time in striking back. The drugmaker just launched a direct-to-consumer online pharmacy, slashing Wegovy's price to $499 a monthfar below its $1,350 list price, though still ...

Novo Nordisk wasted no time in striking back. The drugmaker just launched a direct-to-consumer online pharmacy, slashing Wegovy's price to $499 a monthfar below its $1,350 list price, though still ...

Shares of Hims & Hers (HIMS) are down $3.47, or 8%, to $37.50 in pre-market trading after a court denied a motion for a preliminary injunction that two compounding groups – the Outsourcing ...

Telehealth company Hims & Hers Health (HIMS) witnessed a major dip in its stock recently despite reporting 95% revenue growth for the fourth quarter of 2024 and a notable jump in earnings.

We exist in an image-conscious world where weight loss has become a common goal that most people wrestle with at some point in their lives. With the rise of weight loss injections like Ozempic and ...